Viewing Study NCT00099905


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-03-01 @ 3:02 AM
Study NCT ID: NCT00099905
Status: COMPLETED
Last Update Posted: 2012-05-02
First Post: 2004-12-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module